Content
Frontiers of Medicine >> 2022, Volume 16, Issue 3 doi: 10.1007/s11684-021-0858-1
IRF4 and IRF8 expression are associated with clinical phenotype and clinico-hematological response to hydroxyurea in essential thrombocythemia
Abstract
Keywords
myeloproliferative neoplasms ; IRF4 ; IRF8 ; hydroxyurea ; essential thrombocythemia
Content